Home
Login
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
Publ. Version/Full Text
Research data
DOI
PMC
 |
Open Access Hybrid |
|
as soon as is submitted to ZB.
Pathogenicity of NUSAP1 variants is defined by NMD-Escape: Evidence from two novel cases and systematic population-based variant analysis.
Clin. Genet., DOI: 10.1111/cge.70244 (2026)
Protein-truncating variants in the 3' region of a transcript, evading mRNA degradation and giving rise to aberrant truncated proteins, are an underrecognized cause in Mendelian diseases. Here, we report two individuals with heterozygous de novo nonsense variants in the penultimate and last exon of NUSAP1, both presenting with early-onset refractory epilepsy, global developmental delay, congenital microcephaly, and a recognizable facial gestalt. RNA sequencing performed in one individual did not show a reduction in expression, compatible with escape of aberrant transcripts from nonsense mediated mRNA decay (NMD). We systematically analyzed gnomAD population data to delineate a critical region at the 3' region of NUSAP1, where nonsense variants introduce a premature termination codon and escape NMD. Such variants are absent from healthy controls, while frameshift variants producing C-terminal elongations appear tolerated. This position-dependent model provides guidance for diagnostic variant interpretation.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Nusap1 ; Microcephaly ; Nonsense‐mediated Decay ; Protein‐truncating Variants; Messenger-rna Decay; Nonsense; Binding; Genes
ISSN (print) / ISBN
0009-9163
e-ISSN
1399-0004
Journal
Clinical Genetics
Publisher
Wiley
Publishing Place
111 River St, Hoboken 07030-5774, Nj Usa
Reviewing status
Peer reviewed
Institute(s)
Institiute of Neurogenomics (ING)
Grants
Technical University of Munich-Institute for Advanced Study